Chalazion Clinical Trial
Official title:
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (SUN-131-03)
This protocol for SUN-131 1.5% TDS is developed for the treatment of chalazion. SUN-131 1.5% TDS is designed for local delivery of a corticosteroid, to the upper or lower eyelid. The purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as compared with placebo TDS in the treatment of a chalazion.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01202747 -
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
|
Phase 2/Phase 3 | |
| Completed |
NCT02338648 -
Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
|
Phase 2 | |
| Completed |
NCT00420628 -
Pediatric Zylet Safety and Efficacy Study
|
Phase 4 | |
| Withdrawn |
NCT01763437 -
Intralesional Tetracycline Injection in the Treatment of Chalazia
|
Phase 0 | |
| Recruiting |
NCT05070611 -
Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia
|
N/A | |
| Completed |
NCT00832130 -
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
|
N/A | |
| Completed |
NCT04342507 -
Probiotics for Treatment of Chalazion in Adults
|
N/A | |
| Completed |
NCT04322500 -
Probiotics for Chalaziosis Treatment in Children
|
N/A | |
| Recruiting |
NCT02025023 -
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
|
Phase 3 | |
| Recruiting |
NCT05512572 -
Therapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion
|
N/A |